Feed GRRMF
GR

Gerresheimer AG

GRRMF · OTC

$29.05 +0.00% (+$0.00)
Market Cap 891.4M €
P/E Ratio -
Div. Yield -
ROE 23.57%

Bulios Fair Price

$18.82

35.2% downside

Current Price

$29.05

Undervalued Fair Value Overvalued

According to Bulios Fair Price, GRRMF is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Weak
3/9
Valuation
93 /100
Cheap
EV/EBITDA 8.42x
P/S 0.38x
P/B 0.82x
Growth
64 /100
Stable
EPS growth 6.00%
Rev. growth 10.77%
Book val. growth 15.49%
Profitability
8 /100
Weak
Gross margin 23.62%
Net margin 13.80%
Op. margin 9.02%
Quality
6 /100
Poor
ROIC 5.76%
ROE 23.57%
ROA 7.13%
Debt
8 /100
High
Debt/Equity 2.13x
Current ratio 0.81x
Int. coverage -0.86x
Stability
87 /100
Stable
Beta 0.47x
Rev. volatility 9.60%
EPS volatility 13.16%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about GRRMF
Online

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Uwe Ferdinand Röhrhoff

Employees

13,528

Headquarters

Düsseldorf

Upcoming events

04 NOV

Earnings

Upcoming earnings report

28d
25 NOV

Earnings

Upcoming earnings report

49d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.